Literature DB >> 8462771

Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies.

M Boemi1, R W James, F Romagnoli, P Gerber, D Pometta, P Fumelli.   

Abstract

Apolipoprotein E polymorphism was examined in an Italian population of Type 2 (non-insulin-dependent) diabetic patients. There were significant differences (p < 0.05) in allele frequencies between male and female patients due to an under-representation of the E4 allele in the female group. No differences in allele frequencies were noted when non-diabetic male and female control subjects were compared. Both control groups exhibited similar allele distributions to that of male diabetic patients, but were significantly different (p < 0.05) from female diabetic patients. A closer examination of the female diabetic population revealed that under-representation of the E4 allele was principally confined to patients aged 60 years or older. This subgroup showed a significantly different (p < 0.05) allele frequency profile from control subjects (both men and women) and diabetic men, whereas this was not observed in the younger diabetic women (< or = 59 years). The results are consistent with the suggestion that the E4 allele may be a particular risk factor for female diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462771     DOI: 10.1007/bf00399955

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

2.  Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus.

Authors:  Y Imari; S Koga; H Ibayashi
Journal:  Metabolism       Date:  1988-12       Impact factor: 8.694

3.  Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.

Authors:  R W James; D Pometta
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

4.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

5.  Plasma lipids and diabetes mellitus in an adult community.

Authors:  E Barrett-Connor; S M Grundy; M J Holdbrook
Journal:  Am J Epidemiol       Date:  1982-05       Impact factor: 4.897

Review 6.  Apolipoprotein E polymorphism in health and disease.

Authors:  G Utermann
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

Review 7.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

8.  Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms.

Authors:  J M Ordovas; L Litwack-Klein; P W Wilson; M M Schaefer; E J Schaefer
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

9.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

10.  Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease.

Authors:  H J Lenzen; G Assmann; R Buchwalsky; H Schulte
Journal:  Clin Chem       Date:  1986-05       Impact factor: 8.327

View more
  1 in total

1.  Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients.

Authors:  Sherine Maher Rizk; Nagwa Ali Sabri
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.